KBC Group NV Grows Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

KBC Group NV raised its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 46.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,337 shares of the company’s stock after purchasing an additional 2,324 shares during the quarter. KBC Group NV’s holdings in Option Care Health were worth $170,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Westfield Capital Management Co. LP grew its position in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares in the last quarter. Global Alpha Capital Management Ltd. boosted its holdings in shares of Option Care Health by 108.3% in the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock worth $1,559,000 after purchasing an additional 25,905 shares during the period. Graypoint LLC bought a new position in shares of Option Care Health during the 4th quarter valued at approximately $1,161,000. Victory Capital Management Inc. raised its holdings in Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after buying an additional 1,585,818 shares during the period. Finally, Barclays PLC lifted its position in Option Care Health by 180.1% in the third quarter. Barclays PLC now owns 310,194 shares of the company’s stock worth $9,708,000 after buying an additional 199,454 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the company’s stock in a transaction on Friday, November 8th. The shares were bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of research analysts have weighed in on OPCH shares. Barrington Research boosted their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research report on Tuesday, January 14th. UBS Group assumed coverage on shares of Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price target on the stock. JMP Securities reissued a “market outperform” rating and issued a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Truist Financial dropped their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $38.00 to $27.00 in a report on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $31.32 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $5.33 billion, a PE ratio of 26.32, a price-to-earnings-growth ratio of 2.19 and a beta of 1.35. The firm’s 50 day simple moving average is $25.60 and its 200-day simple moving average is $27.88. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.